Related references
Note: Only part of the references are listed.Human mesenchymal stromal cells deliver systemic oncolytic measles virus to treat acute lymphoblastic leukemia in the presence of humoral immunity
Anna Castleton et al.
BLOOD (2014)
CD40 ligand and tdTomato-armed vaccinia virus for induction of antitumor immune response and tumor imaging
S. Parviainen et al.
GENE THERAPY (2014)
Telomerase-specific oncolytic adenovirus: Antitumor effects on radiation-resistant head and neck squamous cell carcinoma cells
Hideaki Takahashi et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2014)
In vivo magnetic resonance imaging and spectroscopy identifies oncolytic adenovirus responders
O. Hemminki et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
Mitophagy Enhances Oncolytic Measles Virus Replication by Mitigating DDX58/RIG-I-Like Receptor Signaling
Mao Xia et al.
JOURNAL OF VIROLOGY (2014)
Cytokine-enhanced intravenous oncolytic virotherapy
Oliver Donnelly et al.
LANCET (2014)
Sindbis Viral Vectors Transiently Deliver Tumor-associated Antigens to Lymph Nodes and Elicit Diversified Antitumor CD8+ T-cell Immunity
Tomer Granot et al.
MOLECULAR THERAPY (2014)
Oncolytic Virotherapy and Immunogenic Cancer Cell Death: Sharpening the Sword for Improved Cancer Treatment Strategies
Samuel T. Workenhe et al.
MOLECULAR THERAPY (2014)
Maraba Virus as a Potent Oncolytic Vaccine Vector
Jonathan G. Pol et al.
MOLECULAR THERAPY (2014)
Immunogenic HSV-mediated Oncolysis Shapes the Antitumor Immune Response and Contributes to Therapeutic Efficacy
Samuel T. Workenhe et al.
MOLECULAR THERAPY (2014)
A Phase 1 Trial of Oncolytic HSV-1, G207, Given in Combination With Radiation for Recurrent GBM Demonstrates Safety and Radiographic Responses
James M. Markert et al.
MOLECULAR THERAPY (2014)
Smac mimetics and innate immune stimuli synergize to promote tumor death
Shawn T. Beug et al.
NATURE BIOTECHNOLOGY (2014)
Histone Deacetylase Inhibitors Improve the Replication of Oncolytic Herpes Simplex Virus in Breast Cancer Cells
James J. Cody et al.
PLOS ONE (2014)
Localized Oncolytic Virotherapy Overcomes Systemic Tumor Resistance to Immune Checkpoint Blockade Immunotherapy
Dmitriy Zamarin et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Immunostimulatory monoclonal antibodies in cancer therapy
Fernando Aranda et al.
ONCOIMMUNOLOGY (2014)
Trial Watch Adoptive cell transfer for anticancer immunotherapy
Fernando Aranda et al.
ONCOIMMUNOLOGY (2014)
Tumor-Specific Cytolysis Caused by an E1B55K-Attenuated Adenovirus in Nasopharyngeal Carcinoma is Augmented by Cisplatin
Ran-Yi Liu et al.
ANATOMICAL RECORD-ADVANCES IN INTEGRATIVE ANATOMY AND EVOLUTIONARY BIOLOGY (2013)
Immunogenic Cell Death in Cancer Therapy
Guido Kroemer et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 31 (2013)
Oncolytic adenovirus encoding tumor necrosis factor-related apoptosis inducing ligand (TRAIL) inhibits the growth and metastasis of triple-negative breast cancer
Wei Zhu et al.
CANCER BIOLOGY & THERAPY (2013)
Combination of vinblastine and oncolytic herpes simplex virus vector expressing IL-12 therapy increases antitumor and antiangiogenic effects in prostate cancer models
B. J. Passer et al.
CANCER GENE THERAPY (2013)
Toca 511 gene transfer and 5-fluorocytosine in combination with temozolomide demonstrates synergistic therapeutic efficacy in a temozolomide-sensitive glioblastoma model
T. T. Huang et al.
CANCER GENE THERAPY (2013)
Potent antitumoral effects of targeted promoter-driven oncolytic adenovirus armed with Dm-dNK for breast cancer in vitro and in vivo
Xiaoshen Dong et al.
CANCER LETTERS (2013)
Macrophage Delivery of an Oncolytic Virus Abolishes Tumor Regrowth and Metastasis after Chemotherapy or Irradiation
Munitta Muthana et al.
CANCER RESEARCH (2013)
Vascular Normalization as an Emerging Strategy to Enhance Cancer Immunotherapy
Yuhui Huang et al.
CANCER RESEARCH (2013)
Myeloid-Derived Suppressor Cells as a Vehicle for Tumor-Specific Oncolytic Viral Therapy
Samuel Eisenstein et al.
CANCER RESEARCH (2013)
Specific Elimination of CD133+ Tumor Cells with Targeted Oncolytic Measles Virus
Patricia Bach et al.
CANCER RESEARCH (2013)
Oncolytic Vaccinia Virus Disrupts Tumor-Associated Vasculature in Humans
Caroline J. Breitbach et al.
CANCER RESEARCH (2013)
13-Cis retinoic acid can enhance the antitumor activity of non-replicating Sendai virus particle against neuroblastoma
Motonari Nomura et al.
CANCER SCIENCE (2013)
Measles Virus Vaccine-Infected Tumor Cells Induce Tumor Antigen Cross-Presentation by Human Plasmacytoid Dendritic Cells
Jean-Baptiste Guillerme et al.
CLINICAL CANCER RESEARCH (2013)
Antiviral and Antitumor T-cell Immunity in Patients Treated with GM-CSF-Coding Oncolytic Adenovirus
Anna Kanerva et al.
CLINICAL CANCER RESEARCH (2013)
Oncolytic Virotherapy Trials-Letter
Akseli Hemminki et al.
CLINICAL CANCER RESEARCH (2013)
Anti-tumor effects of inactivated Sendai virus particles with an IL-2 gene on angiosarcoma
Yuki Takehara et al.
CLINICAL IMMUNOLOGY (2013)
Current status of gene therapy for cancer
Wolfgang Walther et al.
CURRENT OPINION IN ONCOLOGY (2013)
Measles virus causes immunogenic cell death in human melanoma
O. G. Donnelly et al.
GENE THERAPY (2013)
Anti-angiogenic therapy increases intratumoral adenovirus distribution by inducing collagen degradation
B. Thaci et al.
GENE THERAPY (2013)
Synergistic cytotoxicity of oncolytic reovirus in combination with cisplatin-paclitaxel doublet chemotherapy
V. Roulstone et al.
GENE THERAPY (2013)
Using clinically approved cyclophosphamide regimens to control the humoral immune response to oncolytic viruses
K-W Peng et al.
GENE THERAPY (2013)
Efficacy of oncolytic adenovirus expressing suicide genes and interleukin-12 in preclinical model of prostate cancer
S. O. Freytag et al.
GENE THERAPY (2013)
An armed oncolytic measles vaccine virus eliminates human hepatoma cells independently of apoptosis
J. Lampe et al.
GENE THERAPY (2013)
Enhanced killing of ovarian carcinoma using oncolytic measles vaccine virus armed with a yeast cytosine deaminase and uracil phosphoribosyltransferase
A. D. Hartkopf et al.
GYNECOLOGIC ONCOLOGY (2013)
A phase I clinical trial of Ad5/3-Δ24, a novel serotype-chimeric, infectivity-enhanced, conditionally-replicative adenovirus (CRAd), in patients with recurrent ovarian cancer
Kenneth H. Kim et al.
GYNECOLOGIC ONCOLOGY (2013)
Granulocyte-Macrophage Colony-Stimulating Factor-Armed Oncolytic Measles Virus Is an Effective Therapeutic Cancer Vaccine
Christian Grossardt et al.
HUMAN GENE THERAPY (2013)
Tat-PTD-Modified Oncolytic Adenovirus Driven by the SCG3 Promoter and ASH1 Enhancer for Neuroblastoma Therapy
Chuan Jin et al.
HUMAN GENE THERAPY (2013)
[18F]-Fluorodeoxyglucose Positron Emission Tomography and Computed Tomography in Response Evaluation of Oncolytic Adenovirus Treatments of Patients with Advanced Cancer
Anniina Koski et al.
HUMAN GENE THERAPY (2013)
Anticancer Chemotherapy-Induced Intratumoral Recruitment and Differentiation of Antigen-Presenting Cells
Yuting Ma et al.
IMMUNITY (2013)
Mechanism of Action of Conventional and Targeted Anticancer Therapies: Reinstating Immunosurveillance
Laurence Zitvogel et al.
IMMUNITY (2013)
The role of GM-CSF in enhancing immunotherapy of cancer
Steve H. Thorne
IMMUNOTHERAPY (2013)
Cytotoxic and immune-mediated killing of human colorectal cancer by reovirus-loaded blood and liver mononuclear cells
Robert A. Adair et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
Telomerase-specific oncolytic adenoviral therapy for orthotopic hepatocellular carcinoma in HBx transgenic mice
Wei-Hsiang Lin et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
An armed oncolytic herpes simplex virus expressing thrombospondin-1 has an enhanced in vivo antitumor effect against human gastric cancer
Toshiaki Tsuji et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
Activation of the human immune system via toll-like receptors by the oncolytic parvovirus H-1
Maike Sieben et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
Enhanced antitumoral activity of oncolytic herpes simplex virus with gemcitabine using colorectal tumor models
Shinichi Esaki et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
Cyclophosphamide enhances antitumor efficacy of oncolytic adenovirus expressing uracil phosphoribosyltransferase (UPRT) in immunocompetent Syrian hamsters
Naoyuki Hasegawa et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
REO-001: A phase I trial of percutaneous intralesional administration of reovirus type 3 dearing (Reolysin®) in patients with advanced solid tumors
Don G. Morris et al.
INVESTIGATIONAL NEW DRUGS (2013)
Decoding cell death signals in liver inflammation
Catherine Brenner et al.
JOURNAL OF HEPATOLOGY (2013)
Systemically delivered measles virus-infected mesenchymal stem cells can evade host immunity to inhibit liver cancer growth
Hooi-Tin Ong et al.
JOURNAL OF HEPATOLOGY (2013)
Oncolytic adenovirus co-expressing miRNA-34a and IL-24 induces superior antitumor activity in experimental tumor model
Wenjia Lou et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2013)
Selective Tropism of Seneca Valley Virus for Variant Subtype Small Cell Lung Cancer
J. T. Poirier et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2013)
Live viruses to treat cancer
Oliver Donnelly et al.
JOURNAL OF THE ROYAL SOCIETY OF MEDICINE (2013)
Optimizing patient derived mesenchymal stem cells as virus carriers for a Phase I clinical trial in ovarian cancer
Emily K. Mader et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2013)
Fc-gamma receptor polymorphisms as predictive and prognostic factors in patients receiving oncolytic adenovirus treatment
Mari Hirvinen et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2013)
Antitumor efficacy of a recombinant adenovirus encoding endostatin combined with an E1B55KD-deficient adenovirus in gastric cancer cells
Li-xia Li et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2013)
Prostate-Specific Antigen-Retargeted Recombinant Newcastle Disease Virus for Prostate Cancer Virotherapy
Raghunath Shobana et al.
JOURNAL OF VIROLOGY (2013)
Neuroattenuation of Vesicular Stomatitis Virus through Picornaviral Internal Ribosome Entry Sites
Arun Ammayappan et al.
JOURNAL OF VIROLOGY (2013)
Innate Immune Defense Defines Susceptibility of Sarcoma Cells to Measles Vaccine Virus-Based Oncolysis
Susanne Berchtold et al.
JOURNAL OF VIROLOGY (2013)
Cancer targeting gene-viro-therapy for pancreatic cancer using oncolytic adenovirus ZD55-IL-24 in immune-competent mice
Bin He et al.
MOLECULAR BIOLOGY REPORTS (2013)
Oncolytic viruses as therapeutic cancer vaccines
David L. Bartlett et al.
MOLECULAR CANCER (2013)
Crosstalk Between Immune Cell and Oncolytic Vaccinia Therapy Enhances Tumor Trafficking and Antitumor Effects
Padma Sampath et al.
MOLECULAR THERAPY (2013)
Panorama From the Oncolytic Virotherapy Summit 7th International Summit on Oncolytic Viral Therapeutics Quebec, Canada, 15-18 June 2013
Jonathan G. Pol et al.
MOLECULAR THERAPY (2013)
The Efficacy Versus Toxicity Profile of Combination Virotherapy and TLR Immunotherapy Highlights the Danger of Administering TLR Agonists to Oncolytic Virus-treated Mice
Diana M. Rommelfanger et al.
MOLECULAR THERAPY (2013)
HDAC Inhibition Suppresses Primary Immune Responses, Enhances Secondary Immune Responses, and Abrogates Autoimmunity During Tumor Immunotherapy
Byram W. Bridle et al.
MOLECULAR THERAPY (2013)
Oncolytic Adenovirus With Temozolomide Induces Autophagy and Antitumor Immune Responses in Cancer Patients
Ilkka Liikanen et al.
MOLECULAR THERAPY (2013)
Suppression of Antiviral Innate Immunity by Sunitinib Enhances Oncolytic Virotherapy
Babal K. Jha et al.
MOLECULAR THERAPY (2013)
Effective Treatment of an Orthotopic Xenograft Model of Human Glioblastoma Using an EGFR-retargeted Oncolytic Herpes Simplex Virus
Hiroaki Uchida et al.
MOLECULAR THERAPY (2013)
Randomized dose-finding clinical trial of oncolytic immunotherapeutic vaccinia JX-594 in liver cancer
Jeong Heo et al.
NATURE MEDICINE (2013)
MicroRNA-Mediated Suppression of Oncolytic Adenovirus Replication in Human Liver
Erkko Ylosmaki et al.
PLOS ONE (2013)
Molecular Basis for Viral Selective Replication in Cancer Cells: Activation of CDK2 by Adenovirus-Induced Cyclin E
Pei-Hsin Cheng et al.
PLOS ONE (2013)
Anti-Tumor Activity of a miR-199-dependent Oncolytic Adenovirus
Elisa Callegari et al.
PLOS ONE (2013)
Oncolytic Adenovirus Expressing IL-23 and p35 Elicits IFN-γ- and TNF-α-Co-Producing T Cell-Mediated Antitumor Immunity
Il-Kyu Choi et al.
PLOS ONE (2013)
STAT3 Activation Promotes Oncolytic HSV1 Replication in Glioma Cells
Kazuo Okemoto et al.
PLOS ONE (2013)
Oncolytic Reovirus in Canine Mast Cell Tumor
Chung Chew Hwang et al.
PLOS ONE (2013)
Production of Bioactive Soluble Interleukin-15 in Complex with Interleukin-15 Receptor Alpha from a Conditionally-Replicating Oncolytic HSV-1
David C. Gaston et al.
PLOS ONE (2013)
Targeting CXCL12/CXCR4 signaling with oncolytic virotherapy disrupts tumor vasculature and inhibits breast cancer metastases
Margaret Gil et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Oncolytic and Immunotherapeutic Vaccinia Induces Antibody-Mediated Complement-Dependent Cancer Cell Lysis in Humans
Mi Kyung Kim et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
A dual-regulated oncolytic adenovirus expressing interleukin-24 sensitizes melanoma cells to temozolomide via the induction of apoptosis
Guan Jiang et al.
TUMOR BIOLOGY (2013)
MicroRNA-145 regulates oncolytic herpes simplex virus-1 for selective killing of human non-small cell lung cancer cells
Jhy-Ming Li et al.
VIROLOGY JOURNAL (2013)
Preclinical evaluation of herpes simplex virus armed with granulocyte-macrophage colony-stimulating factor in pancreatic carcinoma
Hao Liu et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2013)
Reolysin is a novel reovirus-based agent that induces endoplasmic reticular stress-mediated apoptosis in pancreatic cancer
J. S. Carew et al.
CELL DEATH & DISEASE (2013)
Non-replicating rhabdovirus-derived particles (NRRPs) eradicate acute leukemia by direct cytolysis and induction of antitumor immunity
C. Batenchuk et al.
BLOOD CANCER JOURNAL (2013)
Preclinical Therapy of Disseminated HER-2+ Ovarian and Breast Carcinomas with a HER-2-Retargeted Oncolytic Herpesvirus
Patrizia Nanni et al.
PLOS PATHOGENS (2013)
Natural Oncolytic Activity of Live-Attenuated Measles Virus against Human Lung and Colorectal Adenocarcinomas
Nicolas Boisgerault et al.
BIOMED RESEARCH INTERNATIONAL (2013)
Characterization and evaluation of a new oncolytic Vaccinia Virus strain LIVP6.1.1 for canine cancer therapy
Ivaylo Gentschev et al.
BIOENGINEERED (2013)
Combination of Oncolytic Herpes Simplex Viruses Armed with Angiostatin and IL-12 Enhances Antitumor Efficacy in Human Glioblastoma Models
Wei Zhang et al.
NEOPLASIA (2013)
The microenvironment of human neuroblastoma supports the activation of tumor-associated T lymphocytes
Lena-Maria Carlson et al.
ONCOIMMUNOLOGY (2013)
The IL-15-based superagonist ALT-803 promotes the antigen-independent conversion of memory CD8+ T cells into innate-like effector cells with antitumor activity
Hing C. Wong et al.
ONCOIMMUNOLOGY (2013)
Trial watch Monoclonal antibodies in cancer therapy
Erika Vacchelli et al.
ONCOIMMUNOLOGY (2013)
Single-dose cyclophosphamide synergizes with immune responses to the renal cell cancer vaccine IMA901
Steffen Walter et al.
ONCOIMMUNOLOGY (2013)
An anticancer therapy-elicited immunosurveillance system that eliminates tetraploid cells
Laura Senovilla et al.
ONCOIMMUNOLOGY (2013)
Current trends of anticancer immunochemotherapy
Erika Vacchelli et al.
ONCOIMMUNOLOGY (2013)
Immune modulation of the tumor microenvironment for enhancing cancer immunotherapy
Christel Devaud et al.
ONCOIMMUNOLOGY (2013)
Tumor necrosis factor is dispensable for the success of immunogenic anticancer chemotherapy
Yuting Ma et al.
ONCOIMMUNOLOGY (2013)
Synchronous apoptosis in established tumors leads to the induction of adaptive immunity
Jamie Honeychurch et al.
ONCOIMMUNOLOGY (2013)
Myeloid-derived suppressor cells as a Trojan horse A cellular vehicle for the delivery of oncolytic viruses
Ping-Ying Pan et al.
ONCOIMMUNOLOGY (2013)
Interferon α interferes with immunological tolerance
Christian Becker et al.
ONCOIMMUNOLOGY (2013)
Macrophages increase the resistance of pancreatic adenocarcinoma cells to gemcitabine by upregulating cytidine deaminase
Moran Amit et al.
ONCOIMMUNOLOGY (2013)
Trial Watch Lenalidomide-based immunochemotherapy
Michaela Semeraro et al.
ONCOIMMUNOLOGY (2013)
Cancer immunotherapy turns viral
Lorenzo Galluzzi et al.
ONCOIMMUNOLOGY (2013)
Uncovering a novel mechanism whereby NK cells interfere with glioblastoma virotherapy
Christopher A. Alvarez-Breckenridge et al.
ONCOIMMUNOLOGY (2013)
New immunotherapeutic paradigms for castration-resistant prostate cancer
Lorenzo Galluzzi
ONCOIMMUNOLOGY (2013)
The Janus face of cyclophosphamide A sterile inflammatory response that potentiates cancer immunotherapy
Giovanna Ziccheddu et al.
ONCOIMMUNOLOGY (2013)
Inhibiting the inhibitors Checkpoints blockade in solid tumors
Domenico Mavilio et al.
ONCOIMMUNOLOGY (2013)
Antitumor activity of an immunocytokine composed of an anti-GD2 antibody and the IL-15 superagonist RLI
Marie Vincent et al.
ONCOIMMUNOLOGY (2013)
ATP-dependent recruitment, survival and differentiation of dendritic cell precursors in the tumor bed after anticancer chemotherapy
Yuting Ma et al.
ONCOIMMUNOLOGY (2013)
Trial Watch Anticancer radioimmunotherapy
Erika Vacchelli et al.
ONCOIMMUNOLOGY (2013)
Trial Watch Toll-like receptor agonists for cancer therapy
Erika Vacchelli et al.
ONCOIMMUNOLOGY (2013)
Immunogenic cell death in radiation therapy
Lorenzo Galluzzi et al.
ONCOIMMUNOLOGY (2013)
Rewiring cancer cell death to enhance oncolytic viro-immunotherapy
Samuel T. Workenhe et al.
ONCOIMMUNOLOGY (2013)
Interferon may be back on track to treat acute myeloid leukemia
Evelien L. J. M. Smits et al.
ONCOIMMUNOLOGY (2013)
The RIG-I/MAVS signaling pathway in cancer cell-selective apoptosis
Yasufumi Kaneda
ONCOIMMUNOLOGY (2013)
Trial watch Chemotherapy with immunogenic cell death inducers
Erika Vacchelli et al.
ONCOIMMUNOLOGY (2013)
Myeloid-derived suppressor cells Cellular missiles to target tumors
Dinesh Chandra et al.
ONCOIMMUNOLOGY (2013)
Harnessing the antitumor potential of macrophages for cancer immunotherapy
Kristen B. Long et al.
ONCOIMMUNOLOGY (2013)
Trial Watch Peptide vaccines in cancer therapy
Fernando Aranda et al.
ONCOIMMUNOLOGY (2013)
Trial watch Oncolytic viruses for cancer therapy
Erika Vacchelli et al.
ONCOIMMUNOLOGY (2013)
Oncolytic vesicular stomatitis virus quantitatively and qualitatively improves primary CD8+ T-cell responses to anticancer vaccines
Byram W. Bridle et al.
ONCOIMMUNOLOGY (2013)
Expressing human interleukin-15 from oncolytic vesicular stomatitis virus improves survival in a murine metastatic colon adenocarcinoma model through the enhancement of anti-tumor immunity
K. B. Stephenson et al.
CANCER GENE THERAPY (2012)
Antitumoral activity of parvovirus-mediated IL-2 and MCP-3/CCL7 delivery into human pancreatic cancer: implication of leucocyte recruitment
Sebastian Dempe et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2012)
Immune Response Is an Important Aspect of the Antitumor Effect Produced by a CD40L-Encoding Oncolytic Adenovirus
Iulia Diaconu et al.
CANCER RESEARCH (2012)
Oncolytic Immunotherapy of Advanced Solid Tumors with a CD40L-Expressing Replicating Adenovirus: Assessment of Safety and Immunologic Responses in Patients
Sari Pesonen et al.
CANCER RESEARCH (2012)
TRAIL and Noxa Are Selectively Upregulated in Prostate Cancer Cells Downstream of the RIG-I/MAVS Signaling Pathway by Nonreplicating Sendai Virus Particles
Taeko Matsushima-Miyagi et al.
CLINICAL CANCER RESEARCH (2012)
Clinical Development of Oncolytic Viruses in China
Min Liang
CURRENT PHARMACEUTICAL BIOTECHNOLOGY (2012)
Effective Radiovirotherapy for Malignant Gliomas by Using Oncolytic Measles Virus Strains Encoding the Sodium Iodide Symporter (MV-NIS)
Mateusz Opyrchal et al.
HUMAN GENE THERAPY (2012)
Oncolytic Measles Virus Encoding Thyroidal Sodium Iodide Symporter for Squamous Cell Cancer of the Head and Neck Radiovirotherapy
Hongtao Li et al.
HUMAN GENE THERAPY (2012)
Retargeting Vesicular Stomatitis Virus Using Measles Virus Envelope Glycoproteins
Camilo Ayala-Breton et al.
HUMAN GENE THERAPY (2012)
Integrin targeted oncolytic adenoviruses Ad5-D24-RGD and Ad5-RGD-D24-GMCSF for treatment of patients with advanced chemotherapy refractory solid tumors
Sari Pesonen et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Enhanced oncolysis mediated by Coxsackievirus A21 in combination with doxorubicin hydrochloride
Kathryn A. Skelding et al.
INVESTIGATIONAL NEW DRUGS (2012)
Oncolytic virotherapy in veterinary medicine: current status and future prospects for canine patients
Sandeep S. Patil et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2012)
A First in Human Phase 1 Study of CG0070, a GM-CSF Expressing Oncolytic Adenovirus, for the Treatment of Nonmuscle Invasive Bladder Cancer
James M. Burke et al.
JOURNAL OF UROLOGY (2012)
An Oncolytic Adenovirus Enhanced for Toll-like Receptor 9 Stimulation Increases Antitumor Immune Responses and Tumor Clearance
Vincenzo Cerullo et al.
MOLECULAR THERAPY (2012)
Design and Selection of Toca 511 for Clinical Use: Modified Retroviral Replicating Vector With Improved Stability and Gene Expression
Omar D. Perez et al.
MOLECULAR THERAPY (2012)
Oncolytic virotherapy
Stephen J. Russell et al.
NATURE BIOTECHNOLOGY (2012)
The secret ally: immunostimulation by anticancer drugs
Lorenzo Galluzzi et al.
NATURE REVIEWS DRUG DISCOVERY (2012)
Mitochondria: master regulators of danger signalling
Lorenzo Galluzzi et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2012)
Brain tumor eradication and prolonged survival from intratumoral conversion of 5-fluorocytosine to 5-fluorouracil using a nonlytic retroviral replicating vector
Derek Ostertag et al.
NEURO-ONCOLOGY (2012)
Molecular mechanisms of cisplatin resistance
L. Galluzzi et al.
ONCOGENE (2012)
Oncolytic Effects of a Novel Influenza A Virus Expressing Interleukin-15 from the NS Reading Frame
Marijke van Rikxoort et al.
PLOS ONE (2012)
Preclinical Evaluation of Oncolytic Vaccinia Virus for Therapy of Canine Soft Tissue Sarcoma
Ivaylo Gentschev et al.
PLOS ONE (2012)
Virotherapy of Canine Tumors with Oncolytic Vaccinia Virus GLV-1h109 Expressing an Anti-VEGF Single-Chain Antibody
Sandeep S. Patil et al.
PLOS ONE (2012)
An Immunosurveillance Mechanism Controls Cancer Cell Ploidy
Laura Senovilla et al.
SCIENCE (2012)
Prognostic Impact of Vitamin B6 Metabolism in Lung Cancer
Lorenzo Galluzzi et al.
CELL REPORTS (2012)
Expression of CCL19 from Oncolytic Vaccinia Enhances Immunotherapeutic Potential while Maintaining Oncolytic Activity
Jun Li et al.
NEOPLASIA (2012)
Activation of systemic antitumor immunity via TRAIL-induced apoptosis
Britnie R. James et al.
ONCOIMMUNOLOGY (2012)
Interleukin-2 treatment of tumor patients can expand regulatory T cells
Marc Beyer
ONCOIMMUNOLOGY (2012)
Viral antigen mediated NKp46 activation of NK cells results in tumor rejection via NK-DC crosstalk
Fay Chinnery et al.
ONCOIMMUNOLOGY (2012)
Single low-dose cyclophosphamide combined with interleukin-12 gene therapy is superior to a metronomic schedule in inducing immunity against colorectal carcinoma in mice
Mariana Malvicini et al.
ONCOIMMUNOLOGY (2012)
Chemoimmunotherapy as long-term maintenance therapy for cancer
Nejat K. Egilmez et al.
ONCOIMMUNOLOGY (2012)
Virus infections in tumors pave the way for tumor-directed DC-vaccines
Norman Woller et al.
ONCOIMMUNOLOGY (2012)
Virotherapy, gene transfer and immunostimulatory monoclonal antibodies
Jose I. Quetglas et al.
ONCOIMMUNOLOGY (2012)
A model for cancer-suppressive inflammation
Ole Audun Werner Haabeth et al.
ONCOIMMUNOLOGY (2012)
Trial watch Chemotherapy with immunogenic cell death inducers
Erika Vacchelli et al.
ONCOIMMUNOLOGY (2012)
Dendritic cell exosomes directly kill tumor cells and activate natural killer cells via TNF superfamily ligands
Stephan Munich et al.
ONCOIMMUNOLOGY (2012)
Trial watch Prognostic and predictive value of the immune infiltrate in cancer
Laura Senovilla et al.
ONCOIMMUNOLOGY (2012)
Trial watch FDA-approved Toll-like receptor agonists for cancer therapy
Erika Vacchelli et al.
ONCOIMMUNOLOGY (2012)
Systemic Delivery of Oncolytic Viruses: Hopes and Hurdles
Mark S. Ferguson et al.
ADVANCES IN VIROLOGY (2012)
Oncolytic Viruses: The Power of Directed Evolution
Maxine Bauzon et al.
ADVANCES IN VIROLOGY (2012)
Molecular determinants of immunogenic cell death elicited by anticancer chemotherapy
Oliver Kepp et al.
CANCER AND METASTASIS REVIEWS (2011)
Enhancing VSV oncolytic activity with an improved cytosine deaminase suicide gene strategy
S. Leveille et al.
CANCER GENE THERAPY (2011)
Prognostic and Predictive Impact of Intra- and Peritumoral Immune Infiltrates
Wolf Herman Fridman et al.
CANCER RESEARCH (2011)
Illicit survival of cancer cells during polyploidization and depolyploidization
I. Vitale et al.
CELL DEATH AND DIFFERENTIATION (2011)
Enhanced Safety Profiles of the Telomerase-Specific Replication-Competent Adenovirus by Incorporation of Normal Cell-Specific microRNA-Targeted Sequences
Kumiko Sugio et al.
CLINICAL CANCER RESEARCH (2011)
Pseudotyping Vesicular Stomatitis Virus with Lymphocytic Choriomeningitis Virus Glycoproteins Enhances Infectivity for Glioma Cells and Minimizes Neurotropism
Alexander Muik et al.
JOURNAL OF VIROLOGY (2011)
Precise Scheduling of Chemotherapy Primes VEGF-producing Tumors for Successful Systemic Oncolytic Virotherapy
Timothy Kottke et al.
MOLECULAR THERAPY (2011)
Optimizing DC Vaccination by Combination With Oncolytic Adenovirus Coexpressing IL-12 and GM-CSF
Song-Nan Zhang et al.
MOLECULAR THERAPY (2011)
A Mechanistic Proof-of-concept Clinical Trial With JX-594, a Targeted Multi-mechanistic Oncolytic Poxvirus, in Patients With Metastatic Melanoma
Tae-Ho Hwang et al.
MOLECULAR THERAPY (2011)
Intravenous delivery of a multi-mechanistic cancer-targeted oncolytic poxvirus in humans
Caroline J. Breitbach et al.
NATURE (2011)
Immune parameters affecting the efficacy of chemotherapeutic regimens
Laurence Zitvogel et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2011)
Mitotic catastrophe: a mechanism for avoiding genomic instability
Ilio Vitale et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2011)
NORMALIZATION OF THE VASCULATURE FOR TREATMENT OF CANCER AND OTHER DISEASES
Shom Goel et al.
PHYSIOLOGICAL REVIEWS (2011)
Sodium Iodide Symporter (NIS)-Mediated Radiovirotherapy for Pancreatic Cancer
Alan R. Penheiter et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2010)
Identification of the ENT1 Antagonists Dipyridamole and Dilazep as Amplifiers of Oncolytic Herpes Simplex Virus-1 Replication
Brent J. Passer et al.
CANCER RESEARCH (2010)
Myxoma Virus Virotherapy for Glioma in Immunocompetent Animal Models: Optimizing Administration Routes and Synergy with Rapamycin
XueQing Lun et al.
CANCER RESEARCH (2010)
miR-181a and miR-630 Regulate Cisplatin-Induced Cancer Cell Death
Lorenzo Galluzzi et al.
CANCER RESEARCH (2010)
Preparing an oncolytic poliovirus recombinant for clinical application against glioblastoma multiforme
Christian Goetz et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2010)
Novel oncolytic viruses: Riding high on the next wave?
Marianne M. Stanford et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2010)
Phase I/II Study of Oncolytic Herpes Simplex Virus NV1020 in Patients with Extensively Pretreated Refractory Colorectal Cancer Metastatic to the Liver
Sunil K. Geevarghese et al.
HUMAN GENE THERAPY (2010)
Attenuation of Vesicular Stomatitis Virus Encephalitis through MicroRNA Targeting
Elizabeth J. Kelly et al.
JOURNAL OF VIROLOGY (2010)
Transcriptional and Translational Dual-regulated Oncolytic Herpes Simplex Virus Type 1 for Targeting Prostate Tumors
Cleo Y. F. Lee et al.
MOLECULAR THERAPY (2010)
Potentiating Cancer Immunotherapy Using an Oncolytic Virus
Byram W. Bridle et al.
MOLECULAR THERAPY (2010)
Systemic Therapy of Disseminated Myeloma in Passively Immunized Mice Using Measles Virus-infected Cell Carriers
Chunsheng Liu et al.
MOLECULAR THERAPY (2010)
Hyaluronidase Expression by an Oncolytic Adenovirus Enhances Its Intratumoral Spread and Suppresses Tumor Growth
Sonia Guedan et al.
MOLECULAR THERAPY (2010)
Arsenic trioxide inhibits DNA methyltransferase and restores expression of methylation-silenced CDKN2B/CDKN2A genes in human hematologic malignant cells
Hai-Ying Fu et al.
ONCOLOGY REPORTS (2010)
Gene Therapy: The First Approved Gene-Based Medicines, Molecular Mechanisms and Clinical Indications
J. Raty et al.
Current Molecular Pharmacology (2010)
Systemic targeting of metastatic human breast tumor xenografts by Coxsackievirus A21
Kathryn A. Skelding et al.
BREAST CANCER RESEARCH AND TREATMENT (2009)
Antitumor Activity of an Oncolytic Adenoviral-CD40 Ligand (CD154) Transgene Construct in Human Breast Cancer Cells
Erica M. Gomes et al.
CLINICAL CANCER RESEARCH (2009)
Reovirus-based therapy for cancer
Kevin Kelly et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2009)
Genetically engineered Newcastle disease virus for malignant melanoma therapy
D. Zamarin et al.
GENE THERAPY (2009)
Chemical Modification with High Molecular Weight Polyethylene Glycol Reduces Transduction of Hepatocytes and Increases Efficacy of Intravenously Delivered Oncolytic Adenovirus
Konstantin Doronin et al.
HUMAN GENE THERAPY (2009)
Oncolytic adenovirus mediated Survivin knockdown by RNA interference suppresses human colorectal carcinoma growth in vitro and in vivo
Wei Shen et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2009)
Evaluation of IRES-mediated, cell-type-specific cytotoxicity of poliovirus using a colorimetric cell proliferation assay
Xiaoyi Yang et al.
JOURNAL OF VIROLOGICAL METHODS (2009)
Myxoma Virus Expressing Interleukin-15 Fails To Cause Lethal Myxomatosis in European Rabbits
Jia Liu et al.
JOURNAL OF VIROLOGY (2009)
Vesicular Stomatitis Virus as a Novel Cancer Vaccine Vector to Prime Antitumor Immunity Amenable to Rapid Boosting With Adenovirus
Byram W. Bridle et al.
MOLECULAR THERAPY (2009)
Phase Ib Trial of Mutant Herpes Simplex Virus G207 Inoculated Pre- and Post-tumor Resection for Recurrent GBM
James M. Markert et al.
MOLECULAR THERAPY (2009)
Conditional and reversible disruption of essential herpesvirus proteins
Mandy Glass et al.
NATURE METHODS (2009)
Targeted delivery of a suicide gene to human colorectal tumors by a conditionally replicating vaccinia virus
J. Foloppe et al.
GENE THERAPY (2008)
Use of a targeted oncolytic poxvirus, JX-594, in patients with refractory primary or metastatic liver cancer: a phase I trial
Byeong-Ho Park et al.
LANCET ONCOLOGY (2008)
Delta-24-RGD in combination with RAD001 induces enhanced anti-glioma effect via autophagic cell death
Marta M. Alonso et al.
MOLECULAR THERAPY (2008)
A let-7 microRNA-sensitive vesicular stomatitis virus demonstrates tumor-specific replication
Robert E. Edge et al.
MOLECULAR THERAPY (2008)
Chemical control of protein stability and function in living mice
Laura A. Banaszynski et al.
NATURE MEDICINE (2008)
Engineering microRNA responsiveness to decrease virus pathogenicity
Elizabeth J. Kelly et al.
NATURE MEDICINE (2008)
Reprogrammed viruses as cancer therapeutics: targeted, armed and shielded
Roberto Cattaneo et al.
NATURE REVIEWS MICROBIOLOGY (2008)
Directed Evolution Generates a Novel Oncolytic Virus for the Treatment of Colon Cancer
Irene Kuhn et al.
PLOS ONE (2008)
Viral control of mitochondrial apoptosis
Lorenzo Galluzzi et al.
PLOS PATHOGENS (2008)
Erlotinib exhibits antineoplastic off-target effects in AML and MDS:: a preclinical study
Simone Boehrer et al.
BLOOD (2008)
Seneca valley virus, a systemically deliverable oncolytic picornavirus, and the treatment of neuroendocrine cancers
P. Seshidhar Reddy et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2007)
Examination of the therapeutic potential of Delta-24-RGD in brain tumor stem cells: Role of autophagic, cell death
Hong Jiang et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2007)
Oncolytic viruses in cancer therapy
Markus J. V. Vaha-Koskela et al.
CANCER LETTERS (2007)
Systemic toxicity-efficacy profile of ICOVIR-5, a potent and selective oncolytic adenovirus based on the pRB pathway
Manel Cascallo et al.
MOLECULAR THERAPY (2007)
ICOVIR-5 shows E2F1 addiction and potent antiglioma effect in vivo
Marta M. Alonso et al.
CANCER RESEARCH (2007)
Combination of the oncolytic adenovirus ICOVIR-5 with chemotherapy provides enhanced anti-glioma effect in vivo
M. M. Alonso et al.
CANCER GENE THERAPY (2007)
The antitumor activity of TRAIL and IL-24 with replicating oncolytic adenovirus in colorectal cancer
L. Zhao et al.
CANCER GENE THERAPY (2006)
The oncolytic effect in vivo of reovirus on tumour cells that have survived reovirus cell killing in vitro
T. Alain et al.
BRITISH JOURNAL OF CANCER (2006)
Oncolytic adenoviral vector carrying the cytosine deaminase gene for melanoma gene therapy
Y. Liu et al.
CANCER GENE THERAPY (2006)
Oncolytic capacity of attenuated replicative Semliki Forest virus in human melanoma xenografts in severe combined immunodeficient mice
Markus J. V. Vaha-Koskela et al.
CANCER RESEARCH (2006)
Oncolysis of pancreatic tumour cells by a γ34.5-deleted HSV-1 does not rely upon Ras-activation, but on the Pl 3-kinase pathway
F. Sarinella et al.
GENE THERAPY (2006)
Enhanced baculovirus-mediated transduction of human cancer cells by tumor-homing peptides
Anna R. Makela et al.
JOURNAL OF VIROLOGY (2006)
Concurrent delivery of GM-CSF and B7-1 using an oncolytic adenovirus elicits potent antitumor effect
K-J Choi et al.
GENE THERAPY (2006)
Differentially regulated interferon response determines the outcome of Newcastle disease virus infection in normal and tumor cell lines
Sateesh Krishnamurthy et al.
JOURNAL OF VIROLOGY (2006)
Lentivirus-mediated gene therapy by suppressing survivin in BALB/c nude mice bearing oral squamous cell carcinoma
Gaofeng Jiang et al.
CANCER BIOLOGY & THERAPY (2006)
Overcoming physiologic barriers to cancer treatment by molecularly targeting the tumor microenvironment
R Cairns et al.
MOLECULAR CANCER RESEARCH (2006)
CG0070, a conditionally replicating granulocyte macrophage colony-stimulating factor-armed oncolytic adenovirus for the treatment of bladder cancer
N Ramesh et al.
CLINICAL CANCER RESEARCH (2006)
Combined HSV-TK/IL-2 gene therapy in patients with recurrent glioblastoma multiforme:: biological and clinical results
F Colombo et al.
CANCER GENE THERAPY (2005)
Influenza immunisation in children with solid tumours
J Chisholm et al.
EUROPEAN JOURNAL OF CANCER (2005)
Combination of gemcitabine and Ad5/3-D24, a tropism modified conditionally replicating adenovirus, for the treatment of ovarian cancer
M Raki et al.
GENE THERAPY (2005)
Epidemiology and outcomes of serious influenza-related infections in the cancer population
CD Cooksley et al.
CANCER (2005)
Normalization of tumor vasculature: An emerging concept in antiangiogenic therapy
RK Jain
SCIENCE (2005)
Treatment of rapidly growing K-BALB and CT26 mouse tumours using Semliki Forest virus and its derived vector
JWP Smyth et al.
GENE THERAPY (2005)
Noninvasive dual modality in vivo monitoring of the persistence and potency of a tumor targeted conditionally replicating adenovirus
A Kanerva et al.
GENE THERAPY (2005)
Xenograft models for liver metastasis: Relationship between tumor morphology and adenovirus vector transduction
ZY Li et al.
MOLECULAR THERAPY (2004)
Angiogenesis inhibition by an oncolytic herpes virus expressing interleukin 12
RJ Wong et al.
CLINICAL CANCER RESEARCH (2004)
Systemic therapy of malignant human melanoma tumors by a common cold-producing enterovirus, coxsackievirus A21
DR Shafren et al.
CLINICAL CANCER RESEARCH (2004)
The effect of sequestration by nontarget tissues on anti-tumor efficacy of systemically applied, conditionally replicating adenovirus vectors
KM Bernt et al.
MOLECULAR THERAPY (2003)
LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1
S Hacein-Bey-Abina et al.
SCIENCE (2003)
VSV strains with defects in their ability to shutdown innate immunity are potent systemic anti-cancer agents
DF Stojdl et al.
CANCER CELL (2003)
Enhanced therapeutic efficacy for ovarian cancer with a serotype 3 receptor-targeted oncolytic adenovirus
A Kanerva et al.
MOLECULAR THERAPY (2003)
Acquired resistance to cytolysis of the E1B-attenuated adenovirus, dl1520, in ovarian tumour cell lines
YT Kim et al.
CANCER GENE THERAPY (2003)
Common community respiratory viruses in patients with cancer - More than just common colds
KL Hicks et al.
CANCER (2003)
Preclinical characterization of the antiglioma activity of a tropism-enhanced adenovirus targeted to the retinoblastoma pathway
J Fueyo et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2003)
A novel hypoxia-inducible factor (HIF) activated oncolytic adenovirus for cancer therapy
DE Post et al.
ONCOGENE (2003)
ICP34.5 deleted herpes simplex virus with enhanced oncolytic, immune stimulating, and anti-tumour properties
BL Liu et al.
GENE THERAPY (2003)
A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency
S Hacein-Bey-Abina et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Age-dependent effects of repeated immunization with a first generation adenovirus vector on the immune response and transgene expression in young and old rats
I Massari et al.
EXPERIMENTAL GERONTOLOGY (2002)
Inhibition of murine prostate tumor growth and activation of immunoregulatory cells with recombinant canarypox viruses
TS Griffith et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2001)
Live attenuated measles virus induces regression of human lymphoma xenografts in immunodeficient mice
D Grote et al.
BLOOD (2001)
Oncolytic herpes simplex virus vector with enhanced MHC class I presentation and tumor cell killing
T Todo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Polymer-coated adenovirus permits efficient retargeting and evades neutralising antibodies
KD Fisher et al.
GENE THERAPY (2001)
Intralesional injection of herpes simplex virus 1716 in metastatic melanoma
RM MacKie et al.
LANCET (2001)
A blood-tumor barrier limits gene transfer to experimental liver cancer: the effect of vasoactive compounds
R Bilbao et al.
GENE THERAPY (2000)
Exploiting tumor-specific defects in the interferon pathway with a previously unknown oncolytic virus
DF Stojdl et al.
NATURE MEDICINE (2000)
Adenovirus-mediated transfer of p53 and Fas ligand drastically enhances apoptosis in gliomas
N Shinoura et al.
CANCER GENE THERAPY (2000)
Conditionally replicating herpes simplex virus mutant, G207 for the treatment of malignant glioma: results of a phase I trial
JM Markert et al.
GENE THERAPY (2000)
Complement depletion facilitates the infection of multiple brain tumors by an intravascular, replication-conditional herpes simplex virus mutant
K Ikeda et al.
JOURNAL OF VIROLOGY (2000)
Engineered herpes simplex virus expressing IL-12 in the treatment of experimental murine brain tumors
JN Parker et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Share Paper
